Denileukin Diftitox

From WikiMD.org
Jump to navigation Jump to search
Denileukin Diftitox
TermDenileukin Diftitox
Short definitionDenileukin Diftitox - (pronounced) (DEH-nih-LOO-kin DIF-tih-tox) drug used to treat adults with cutaneous T-cell lymphoma that has come back (recurred) or has not improved with other treatments. It is used in patients whose cancer has a receptor for the protein interleukin-2 (IL-2). 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Denileukin Diftitox - (pronounced) (DEH-nih-LOO-kin DIF-tih-tox) drug used to treat adults with cutaneous T-cell lymphoma that has come back (recurred) or has not improved with other treatments. It is used in patients whose cancer has a receptor for the protein interleukin-2 (IL-2). It is also being studied in the treatment of other types of cancer. Denileukin diftitox is made by combining IL-2 with a bacterial toxin. The IL-2 portion of the drug attaches to the cancer cells and the toxin kills them. Denileukin Diftitox is a type of immunotoxin and a type of fusion protein. Also called Ontak

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski